I took Hillary Clinton’s Masterclass in ‘resilience’
So you don’t have to
Politics
Read about the latest political news, views and analysis
Thursday
The war on Christmas comes home
The torching of the Fox News tree calls to mind a culture war gone by
Democrats’ bad year ends with a whimper
Plus: San Francisco has had enough and Psaki bombs
Wednesday
Biden needs to learn to live with the virus
Plus: Amtrak derails its vaccine mandate and more
Democrats whistle past a crime wave
They’d rather deny it exists or blame it on Covid than take action
Adam Carolla mocks the Covid tyrants
More comedians should take aim at the ridiculous world we’ve been forced to live in
Tuesday
Liz Cheney’s high noon
The neocon ogress finds her voice on the January 6 commission
Why Julian Assange is hated
He makes us admit the truth we hide
What Chris Wallace does next
Will the veteran ‘straight news’ man let CNN soil his reputation?
The curious case of Mark Meadows
Plus: Raimondo’s China connection and Biden’s Afghanistan understatement
Monday
Conservatives should support ending the debt ceiling
It’s not worth the risk, or the deal Mitch McConnell just struck to raise it
Why won’t the White House take inflation seriously?
Plus: Covid common sense in Colorado and more
Sunday
What conservatives get right about masculinity
If an entire sex is suffering, the very survival of republican government is at stake
Saturday
Why discord delights
Moderation is for milquetoasts
Friday
No, the media doesn’t treat Biden worse than Trump
A Washington Post writer suggests the absurd
Silence of the Jussie Smollett defenders
It turns out that ‘systemic racism’ is what you have to rely on when there is no actual racism to be found
A bevy of bad news for Biden’s Build Back Better
Plus: Trump turns on Bibi and Biden goes on Fallon
The end of Canadian liberty
Its government slaps on quarantines and snatches rights while its people nod along
Thursday
The rise of the second-string left
Progressives aren’t sending their best — and it’s making a fiscal crisis all the more likely
Is Pfizer about to cash in on the Omicron variant?
Its CEO’s recent comments run counter to those of scientists and suggest a motive: profit